Publication | Closed Access
Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer
104
Citations
77
References
2002
Year
Breast OncologyPotential BenefitsMedicinePharmacologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentIrreversible Pan-erbb InhibitorOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1